AroCell AB — Investor Relations & Filings

IDL Diagnostics AB, formerly AroCell AB, is a diagnostics company that develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology. The company's portfolio aims to provide high-value clinical information for disease detection, prognosis, and monitoring. Key products in oncology include the TK 210 ELISA, a cell proliferation biomarker for assessing therapy response in various cancers, and the UBC® Rapid, a point-of-care test for bladder cancer. In bacteriology, the company provides the TUBEX® TF rapid test for the detection of acute typhoid fever. IDL Diagnostics also licenses tumor markers to strategic partners.